The Food and Drug Administration is likely to take new actions on opioids that may be “disruptive” and “uncomfortable” to drugmakers, the agency’s commissioner said Thursday.
In addition to seeking to treat opioid-addicted patients with alternative medications that don’t produce a high, the FDA says it will look at ways to reduce exposure to the drug. That includes new ways of packaging and distribution.
“For example, it’s possible that a defined, short-term supply of medication could be packaged in a manner that limits the number of pills dispensed,” the FDA said in a statement Monday.
